Search Within

Richard Rifkind

Formats
  1. Journal Article (67)
  2. Meeting Abstract (40)
  3. Book Section (5)
  4. Conference Paper (5)
  5. Review (1)
Groups
  1. Department of Medicine (15)
  2. Center for Hematologic Malignancies (14)
  3. Solid Tumor Oncology Division (12)
  4. Surgery (12)
  5. Genitourinary Oncology Service (10)
  6. Pediatric Leukemia (6)

More Groups

People
  1. Paul Marks (113)
  2. Victoria Richon (76)
  3. Lang Ngo (14)
  4. Hiroaki Kiyokawa (12)
  5. Joseph Michaeli (11)
  6. Xianbo Zhou (11)

More People

Years
  1. 2007 (1)
  2. 2004 (2)
  3. 2003 (3)
  4. 2002 (8)
  5. 2001 (11)
  6. 2000 (11)

More Years

Publications
  1. Proceedings of the National Academy of Sciences of the United States of America (20)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (19)
  3. Cancer Research (11)
  4. Blood (7)
  5. Clinical Cancer Research (7)
  6. Anticancer Research (5)

More Publications

Publishers
  1. American Association for Cancer Research (40)
  2. National Academy of Sciences (20)
  3. American Society of Hematology (7)
  4. International Institute of Anticancer Research (5)
  5. John Wiley & Sons (5)
  6. Elsevier Inc. (4)

More Publishers

Results (118)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells
    Journal Article

    Siegel, D. S.; Zhang, X.; Feinman, R.; Teitz, T.; Zelenetz, A.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.; Michaeli, J.
    Proceedings of the National Academy of Sciences of the United States of America (1998)

    Fulltext@MSK | Save
  • A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
    Journal Article

    Richon, V. M.; Emiliani, S.; Verdin, E.; Webb, Y.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (1998)

    Fulltext@MSK | Save
  • E2F status determines the response of bladder carcinoma cells to differentiation-induction by hybrid polar compounds
    Meeting Abstract

    Richon, V. M.; Russo, P.; Venta-Perez, G.; Cordon-Cardo, C.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1997)

    Fulltext@MSK | Save
  • Second generation hybrid polar compounds are highly potent inducers of differentiation of various types of transformed cells
    Meeting Abstract

    Richon, V. M.; Michaeli, J.; Perrotti, M.; Heston, W.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1997)

    Fulltext@MSK | Save
  • Hybrid polar compounds induce differentiation of human bladder transitional carcinoma cells
    Meeting Abstract

    Richon, V. M.; Venta-Perez, G.; Cordon-Cardo, C.; Russo, P.; Rifkind, R. A.; Marks, P. A.
    Anticancer Research (1997)

    Fulltext@MSK | Save
  • Highly potent hybrid polar compounds (HPC) induce transformed cell to differentiate or apoptose: Targeting cell cycle regulatory proteins
    Meeting Abstract

    Marks, P. A.; Richon, V. M.; Civoli, F.; Venta-Perez, G.; Russo, P.; Rifkind, R. A.
    Anticancer Research (1997)

    Fulltext@MSK | Save
  • HMBA and related compounds induce apoptosis in human myeloma cells
    Meeting Abstract

    Siegel, D.; Tang, B.; Feinman-Siegel, R.; Teitz, T.; Richon, V.; Rifkind, R. A.; Marks, P. A.; Michaeli, J.
    Anticancer Research (1997)

    Fulltext@MSK | Save
  • Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells
    Journal Article

    Richon, V. M.; Russo, P.; Venta-Perez, G.; Cordon-Cardo, C.; Rifkind, R. A.; Marks, P. A.
    Cancer Research (1997)

    Fulltext@MSK | Save
  • Cell cycle regulatory proteins are targets for induced differentiation
    Meeting Abstract

    Marks, P. A.; Richon, V. M.; Rifkind, R. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Highly potent second generation hybrid polar cytodifferentiation agents
    Meeting Abstract

    Richon, V. M.; Ngo, L.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save